- Cannabis acquired an Extraction Machine for $200,000
- Cannabis and its Partners will manufacture their own Oils
- Projected Net revenue for 12 and 24 months is $6,000,000 and $10,000,000 respectively
COCONUT CREEK, Fla., April 20, 2018 -- Via OTC PR Wire – Bahamas Development Corporation (OTCPINK:BDCI) subsidiary company Cannabis Consortium, Inc. has purchased an Oil Extraction machine today that will be leased to its Partners to Distillate and Manufacture Oil.
Cannabis's Partners have several years of experience producing Cannabis Distillate.
With the recent Master License deal with Infused Edibles it was natural fit to move into the production of Cannabis and CBD Oils. The Oil will be needed to infuse the products sold under "Infused Edibles" and marketed to the 400 outlets that Infuse Edibles services already.
The Extraction machine will also be used to produce private label Oil for third parties, Cannabis's Partners have already lined up 5 white label partners.
Both operations will be housed within the building Cannabis is seeking to purchase in Northern California.
Cannabis Consortium has added a new web page to its site www.cannabisconsortium.net called "California Operations". The page has a detailed presentation of how and when revenue will be generated.
Cannabis Consortium does not own or operate any licensed cannabis operations. Cannabis Consortium is entitled to receive 15% of the annual net revenue collected by its partners from every project it is involved with. The Company is also entitled to receive 15% of the proceeds its partners receive should any company be sold. Cannabis acts as a consultant in these transactions and is not involved in any day-to-day operations or decision making for any of the licensed cannabis operations. Cannabis may own assets in the future that are leased to various licensed entities operating in the cannabis sector. Cannabis will receive above average rents from any assets it leases to the cannabis sector.
Bahamas Development Corporation, in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg FD.
Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.
Details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com.
For additional information about this release please contact:
Investor Relations:
Matt Dwyer
[email protected]
www.cannabisconsortium.net
954-906-0098


AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
How Marco Pharma International Preserves German Homeopathic Traditions in America
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 



